U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C30H30N2O3
Molecular Weight 466.5708
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIIL-260

SMILES

CC(C)(C1=CC=C(O)C=C1)C2=CC=C(OCC3=CC(COC4=CC=C(C=C4)C(N)=N)=CC=C3)C=C2

InChI

InChIKey=MBLJFKQACMILLC-UHFFFAOYSA-N
InChI=1S/C30H30N2O3/c1-30(2,24-8-12-26(33)13-9-24)25-10-16-28(17-11-25)35-20-22-5-3-4-21(18-22)19-34-27-14-6-23(7-15-27)29(31)32/h3-18,33H,19-20H2,1-2H3,(H3,31,32)

HIDE SMILES / InChI

Molecular Formula C30H30N2O3
Molecular Weight 466.5708
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
2001 Apr
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.
2007 May
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 02:02:05 GMT 2023
Edited
by admin
on Sat Dec 16 02:02:05 GMT 2023
Record UNII
P3C87ZBO3K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BIIL-260
Code English
BIIL260
Code English
BENZENECARBOXIMIDAMIDE, 4-((3-((4-(1-(4-HYDROXYPHENYL)-1-METHYLETHYL)PHENOXY)METHYL)PHENYL)METHOXY)-
Systematic Name English
Code System Code Type Description
CAS
204974-93-6
Created by admin on Sat Dec 16 02:02:05 GMT 2023 , Edited by admin on Sat Dec 16 02:02:05 GMT 2023
PRIMARY
FDA UNII
P3C87ZBO3K
Created by admin on Sat Dec 16 02:02:05 GMT 2023 , Edited by admin on Sat Dec 16 02:02:05 GMT 2023
PRIMARY
EPA CompTox
DTXSID80174475
Created by admin on Sat Dec 16 02:02:05 GMT 2023 , Edited by admin on Sat Dec 16 02:02:05 GMT 2023
PRIMARY
PUBCHEM
9956189
Created by admin on Sat Dec 16 02:02:05 GMT 2023 , Edited by admin on Sat Dec 16 02:02:05 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
ACTIVE MOIETY